Teva has been through a lot of bad news in the past few years. A bad CEO, a terrible aquisition, lots of debt and then the covid pandemic. i simply think they have been beaten down way too much. There's a new management team in place, debt has been restructured and Teva can get back to the business of selling generic drugs - and it's a good business which Teva does well. Down 55% in one month.. this is a great entry point in my opinion.
Subscribe to:
Post Comments (Atom)
-
Portfolio Performance since Feb 2020 : My Portfolio - 112.11% S&P 500 - 15.45% Nasdaq - 47.99% -
I've been investing for about 20 years. This portfolio is not a retirement portfolio, but an aggressive growth, 'Moonshot' port...
-
I've been looking at the sports betting market for some time now. The US Federal court decision to allow states to open up for legal gam...
No comments:
Post a Comment